An observational, multi-center retrospective cohort study to investigate the treatment persistence and treatment outcomes of Finnish Inflammatory Bowel Disease patients receiving vedolizumab as first-line biological treatment (Finvedo1L)
Changes to the permit: extension of validity
Issuer of the original permit: Findata
Cookies help us to develop our website and to improve its content and availability. Some cookies are necessary to ensure that the website functions properly. You can access the settings later from the Read More page. Cookie settings.
Cookies help us to develop our website and to improve its content and availability. Some cookies are necessary to ensure that the website functions properly. You can accept all cookies or just the necessary cookies.
Some cookies are necessary to ensure that website functions properly. Necessary cookies are used, for example, for functionalities where the user makes selections.
Necessary cookies are stored automatically, without your separate consent, on your browser when you use the website. Necessary cookies are stored on your browser for up to one year.
